Schedule 13D ownership disclosure
Trevi Therapeutics Inc
Security class unavailable · CUSIP: 89532M101
Event date: 2021-10-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 36.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-21-000615
- Form type
- SC 13D
- Filer
- New Enterprise Associates 16, L.P.
- CIK
- CIK 1694560
- Filed
- Nov 02, 2021
- Reporting period
- Oct 18, 2021
- Description
- Schedule 13D beneficial ownership